LENEXA, Kan., May 23, 2005 (PRIMEZONE) -- Mediware Information Systems, Inc. (Nasdaq:MEDW), a known leader in healthcare delivery and patient safety software management solutions, announced today its next generation donor software management system, HCLL(tm) Donor, was cleared by the U.S. Food and Drug Administration (FDA) for sale in the United States.
"Clearance of our HCLL(tm) Donor software has further enhanced Mediware's leading position in providing software solutions to the Blood and Cellular products industry," said Frank Poggio, vice president and general manager of Mediware's Blood Bank Division.
Poggio added, "With the addition of HCLL(tm) Donor software, Mediware's suite of Transfusion and Donor products extends our abilities to serve a broad range of hospitals both in size and complexity. While our LifeTrak(r) Suite of Donor products is geared to free standing blood centers and very large hospital facilities, HCLL(tm) Donor software is the state-of-the-art solution for the small and mid-range in-hospital donor service market. We see many hospital clients expanding their autologous and directed donor programs and HCLL Donor software will help them grow these important areas."
Poggio continued: "HCLL(tm) Donor software is designed to build upon and extend the foundation of the advanced safety features of HCLL(tm) Transfusion and continues Mediware's complete commitment to patient safety. HCLL(tm) Donor software includes enhanced system controls which help assure the safety of products being made available for transfusion."
About Mediware
Mediware provides clinical information systems for hospitals and integrated healthcare delivery systems. It's products include HCLL(tm) Transfusion, HCLL(tm)Donor, LifeTrak(r), IIE(tm) (Instrument Interface Engine), Hemocare(r), LifeLine(tm), (Blood Bank) WORx(r), MediCOE(tm), MediMAR(tm), Pharmakon(r), and Digimedics(tm) (Medication Management), Surgiware(tm) and Perioperative Solutions(tm) (operating room), as well as the JAC Stock Control System (pharmacy) in the United Kingdom. Mediware has over 1,100 systems installed in the U.S., Canada, the U.K., and elsewhere.
Certain statements in this press release may constitute "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the ``Act'') and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2004, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.